Exemestane Supplier-Buyer Network — Trade Flow Analysis

Name: Exemestane Supplier-Buyer Trade Network Dataset — 87+ Indian Exporters, 18+ Importers, 57+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Exemestane supplier network, Exemestane buyers, pharmaceutical export India, Exemestane trade data

TransData Nexus

Exemestane

India Pharmaceutical Trade Intelligence

$14.5M87 Suppliers57 CountriesHS 30049049

ExportsIndia → UNITED STATES39.3%India → BRAZIL12.2%

ImportsUNITED STATES → India$163.0K ITALY → India$146.4K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: CARDINAL HEALTH

Who Supplies Exemestane? Top Manufacturers & Buyers 2026 — INTAS PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the first-largest Exemestane exporter from India, with a market share of 15.7% and a total export value of $2.3M across 260 shipments. Their average shipment value of $8.7K is below the market average of $9.4K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER — $865.3K across 99 shipments (38.2% of this supplier's total exports)

• BROCACEF NL HUB — $553.9K across 63 shipments (24.4% of this supplier's total exports)

• FIEGE HEALTHCARE LOGISTICS GMBH — $382.4K across 44 shipments (16.9% of this supplier's total exports)

• EUROPEAN PHARMAHUB — $267.8K across 31 shipments (11.8% of this supplier's total exports)

• TO THE ORDER — $198.5K across 23 shipments (8.8% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (260 shipments) at a per-shipment value of $8.7K, indicating a broad distribution network with many smaller, regular orders.

2EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Exemestane exporter from India, with a market share of 14.5% and a total export value of $2.1M across 27 shipments. Their average shipment value of $77.7K is above the market average of $9.4K, suggesting premium or bulk contract pricing.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROBINDO PHARMA USA., INC — $709.8K across 9 shipments (33.9% of this supplier's total exports)

• AUROBINDO PHARMA USA., INC — $524.4K across 7 shipments (25.0% of this supplier's total exports)

• AUROBINDO PHARMA USA., INC — $428.6K across 6 shipments (20.4% of this supplier's total exports)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $255.5K across 3 shipments (12.2% of this supplier's total exports)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $178.2K across 2 shipments (8.5% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $77.7K is 722% above the market average of $9.4K, consistent with large-order contracts or value-added formulations.

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the third-largest Exemestane exporter from India, with a market share of 9.8% and a total export value of $1.4M across 18 shipments. Their average shipment value of $78.8K is above the market average of $9.4K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• SUN FARMACUTICA DO BRASIL LTDA, — $365.5K across 5 shipments (25.8% of this supplier's total exports)

• SUN FARMACEUTICA DO — $353.6K across 4 shipments (24.9% of this supplier's total exports)

• SUN FARMACUTICA DO BRASIL LTDA, — $276.7K across 4 shipments (19.5% of this supplier's total exports)

• MS SUN FARMACEUTICA — $244.6K across 3 shipments (17.2% of this supplier's total exports)

• M/S. SUN FARMACEUTIC — $178.2K across 2 shipments (12.6% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $78.8K is 734% above the market average of $9.4K, consistent with large-order contracts or value-added formulations.

4MSN LABORATORIES PRIVATE LIMITED

MSN LABORATORIES PRIVATE LIMITED is the fourth-largest Exemestane exporter from India, with a market share of 6.3% and a total export value of $910.1K across 34 shipments. Their average shipment value of $26.8K is above the market average of $9.4K, suggesting premium or bulk contract pricing.

MSN LABORATORIES PRIVATE LIMITED serves 4 named buyers in our database. CARDINAL HEALTH is the dominant customer, accounting for 54.7% of this supplier's tracked business. Top customers include:

• CARDINAL HEALTH — $498.0K across 19 shipments (54.7% of this supplier's total exports)

• CARDINAL HEALTTH — $177.8K across 7 shipments (19.5% of this supplier's total exports)

• CARDINAL HEALTH LAVE — $177.3K across 7 shipments (19.5% of this supplier's total exports)

• TO THE ORDER OF — $57.0K across 2 shipments (6.3% of this supplier's total exports)

Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $26.8K is 183% above the market average of $9.4K, consistent with large-order contracts or value-added formulations.

5CIPLA LIMITED

CIPLA LIMITED is the fifth-largest Exemestane exporter from India, with a market share of 5.9% and a total export value of $848.2K across 16 shipments. Their average shipment value of $53.0K is above the market average of $9.4K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $373.4K across 7 shipments (44.0% of this supplier's total exports)

• ALTERNAVIDA SA DE — $309.4K across 6 shipments (36.5% of this supplier's total exports)

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $94.4K across 2 shipments (11.1% of this supplier's total exports)

• ALTERNAVIDA SA DE CV — $69.7K across 1 shipments (8.2% of this supplier's total exports)

• JIANGXI HUAYAO PHARM — $1.3K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $53.0K is 461% above the market average of $9.4K, consistent with large-order contracts or value-added formulations.

6TITAN LABORATORIES PRIVATE LIMITED

TITAN LABORATORIES PRIVATE LIMITED is the fifth-largest Exemestane exporter from India, with a market share of 2.1% and a total export value of $309.4K across 10 shipments. Their average shipment value of $30.9K is above the market average of $9.4K, suggesting premium or bulk contract pricing.

TITAN LABORATORIES PRIVATE LIMITED serves 2 named buyers in our database. MORNINGSIDE PHARMACE is the dominant customer, accounting for 76.2% of this supplier's tracked business. Top customers include:

• MORNINGSIDE PHARMACE — $235.8K across 8 shipments (76.2% of this supplier's total exports)

• MPL — $73.7K across 2 shipments (23.8% of this supplier's total exports)

Key Insight: TITAN LABORATORIES PRIVATE LIMITED's per-shipment value of $30.9K is 227% above the market average of $9.4K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Exemestane imports from India, with a total trade value of $5.7M across 60 shipments — representing a 39.3% share of all Exemestane exports. The average shipment value of $94.8K is above the global average of $9.4K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Exemestane importers in United States: CARDINAL HEALTH is the largest buyer, accounting for 19.0% ($1.1M) of this market's total imports.

• CARDINAL HEALTH — $1.1M (19.0% of United States's total)

• AUROBINDO PHARMA USA., INC, — $709.8K (12.5% of United States's total)

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $586.8K (10.3% of United States's total)

Key Insight: United States's per-shipment average of $94.8K (903% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Exemestane imports from India.

Primary Market

Secondary Market

2Brazil

Brazil ranks as the second-largest destination for Exemestane imports from India, with a total trade value of $1.8M across 2 shipments — representing a 12.2% share of all Exemestane exports. The average shipment value of $884.2K is above the global average of $9.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Exemestane importers in Brazil: SUN FARMACUTICA DO BRASIL LTDA, is the largest buyer, accounting for 15.6% ($276.7K) of this market's total imports.

• SUN FARMACUTICA DO BRASIL LTDA, — $276.7K (15.6% of Brazil's total)

Key Insight: Brazil's per-shipment average of $884.2K (9257% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Exemestane imports from India.

Primary Market

Secondary Market

3Netherlands

Netherlands ranks as the third-largest destination for Exemestane imports from India, with a total trade value of $1.7M across 20 shipments — representing a 11.7% share of all Exemestane exports. The average shipment value of $84.7K is above the global average of $9.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Exemestane importers in Netherlands: BROCACEF NL HUB is the largest buyer, accounting for 41.3% ($699.9K) of this market's total imports.

• BROCACEF NL HUB — $699.9K (41.3% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $84.7K (796% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Exemestane imports from India.

Primary Market

Secondary Market

4United Kingdom

United Kingdom ranks as the fourth-largest destination for Exemestane imports from India, with a total trade value of $1.4M across 11 shipments — representing a 9.7% share of all Exemestane exports. The average shipment value of $127.7K is above the global average of $9.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Exemestane importers in United Kingdom: M P L is the largest buyer, accounting for 29.6% ($415.9K) of this market's total imports.

• M P L — $415.9K (29.6% of United Kingdom's total)

• ACCORD UK — $281.6K (20.0% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $127.7K (1251% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Exemestane imports from India.

Primary Market

Secondary Market

5Germany

Germany ranks as the fifth-largest destination for Exemestane imports from India, with a total trade value of $882.2K across 19 shipments — representing a 6.1% share of all Exemestane exports. The average shipment value of $46.4K is above the global average of $9.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Exemestane importers in Germany: FIEGE HEALTHCARE LOGISTICS GMBH is the largest buyer, accounting for 68.5% ($604.5K) of this market's total imports.

• FIEGE HEALTHCARE LOGISTICS GMBH — $604.5K (68.5% of Germany's total)

Key Insight: Germany's per-shipment average of $46.4K (391% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Exemestane imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Exemestane.
2.Flow Mapping: 87 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,533 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 57 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,533 Verified Shipments

87 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Exemestane

Exemestane

Who Supplies Exemestane? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Exemestane? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Exemestane Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1INTAS PHARMACEUTICALS LIMITED

2EUGIA PHARMA SPECIALITIES LIMITED

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

4MSN LABORATORIES PRIVATE LIMITED

5CIPLA LIMITED

6TITAN LABORATORIES PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Exemestane Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Exemestane Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Brazil

3Netherlands

4United Kingdom

5Germany

People Also Ask — Exemestane Supplier & Trade Network

Exemestane Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology